STOCK TITAN

Elvia Cowan sells shares; RSU vesting at PCVX (NASDAQ: PCVX)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

PCVX Form 144 notice reports insider sales of Common Stock by Elvia Cowan. The filing lists a sale of 11,623 shares on 12/23/2025 for $556,971.85 and a sale of 2,500 shares on 03/11/2026 for $146,481.75.

The notice also records recent RSU vesting entries issued by the company on 02/28/2026 (432 shares), 03/02/2026 (580 shares) and 03/07/2026 (880 shares). The report is a near-term disclosure of transactions and issuer-issued vesting events.

Positive

  • None.

Negative

  • None.

Insights

Form 144 discloses two sales by Elvia Cowan and several RSU vesting events.

Form 144 lists a 12/23/2025 disposition of 11,623 shares for $556,971.85 and a 03/11/2026 disposition of 2,500 shares for $146,481.75. These entries are routine disclosure notices required when restricted or control securities are sold under Regulation 144.

The filing also enumerates issuer-recorded RSU vesting on 02/28/2026, 03/02/2026, and 03/07/2026 totaling 1,892 shares. Cash‑flow treatment and any trading plan reference are not provided in the excerpt; subsequent filings or footnotes would clarify whether sales were open‑market or pursuant to other arrangements.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What sales does the PCVX Form 144 report show?

The Form 144 shows sales by Elvia Cowan of 11,623 shares on 12/23/2025 for $556,971.85 and 2,500 shares on 03/11/2026 for $146,481.75. These are the reported dispositions listed in the excerpt.

Does the filing show any RSU vesting at PCVX?

Yes. The excerpt lists RSU vesting by the issuer on 02/28/2026 (432), 03/02/2026 (580) and 03/07/2026 (880), totaling 1,892 shares in the period shown.

Who is the reporting person in the Form 144 excerpt for PCVX?

The reporting person named is Elvia Cowan, with an address in San Carlos, CA. The excerpt attributes the two listed share dispositions to that individual.

Does the excerpt specify how the sales were executed or who received proceeds?

No. The excerpt lists sale dates, share counts, and gross amounts but does not state execution method or which party received proceeds; that detail is not in the provided text.

Are the RSU vesting amounts included among the sold shares in this Form 144?

The excerpt separately lists RSU vesting amounts and the reported dispositions; it does not state that vested RSUs were sold. The relationship between vesting and the sales is not specified in the provided excerpt.
Vaxcyte, Inc.

NASDAQ:PCVX

View PCVX Stock Overview

PCVX Rankings

PCVX Latest News

PCVX Latest SEC Filings

PCVX Stock Data

7.77B
142.97M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
SAN CARLOS